Company addresses FDA requests regarding formulation excipient – Global site start-up activities continue, with first-patient-in for registrational Phase 1b study targeted for Q1 2026, subject to FDA ...
Fiction, nonfiction, memoir, history, essays, language, art history, architecture, climate—we’ve got you covered with this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback